Report center

医药行业医疗(非药)板块2023年三季报总结:Q4环比改善趋势向好-20231103-国泰君安

(行业评级:增持) 投资建议:兼顾业绩和估值,中长期景气度高,竞争优势突出的细分龙头 医疗服务:爱尔眼科、金域医学、固生堂、海吉亚医疗;血制品:天坛生物、华兰生物;疫苗:智飞生物 医疗器械:迈瑞医疗、开立医疗、爱康医疗、普门科技、迪瑞医疗;零售药店:益丰药房、漱玉平民

No subject companies

Publishers

Suggested next hops

Ranked by edge type and evidence strength (max 5). Prefer these over scrolling the full lists.

  1. 1国泰君安Published by or linked to this institution1
  2. 2Medical DevicesSame industry · 1 related reports1

Other hot industries

No related reports

← Back to knowledge graph